LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

NCT00526409 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Prednisolone
DRUG: Daunorubicin
DRUG: Vincristine
DRUG: L-Asparaginase
DRUG: Cyclophosphamide
DRUG: Methotrexate
DRUG: Cytosine Arabinoside

Sponsor

PETHEMA Foundation